- Narrative Type
| - Narrative Text
|
| Additional Text | Shareholders should note the following amendments in relation to certain inadvertent errors in Enclosure 4 of the Invitation to the 2025 AGM ("Enclosure 4"), which are marked in bold: |
| Additional Text | 1. the Director Profiles of Clinical Prof. Emeritus Piyasakol Sakolsatayadorn, M.D. on page 16, Mr. Panote Sirivadhanabhakdi on page 20, Mr. Ueychai Tantha-Obhas on page 24, Mr. Sithichai Chaikriangkrai on page 29 and Dr. Pisanu Vichiensanth on page 34 |
| Additional Text | (equivalent to pages 16, 21, 26, 31 and 36 respectively of the Thai version) of Enclosure 4 have been amended at the item "No. of time(s) to attend the meeting", to reflect the correct number of times they attended BOD meetings and the correct number of BOD meetings held as of 30 September 2024. |
| Additional Text | 2. in addition, page 21 (equivalent to page 23 of the Thai version) of Mr. Panote Sirivadhanabhakdi's Director Profile in Enclosure 4 has been amended to add an additional directorship in other listed companies, under the item "Director in other listed companies". |
| Additional Text | In addition to the above, there has also been an update on page 23 (equivalent to page 25 of the Thai version) of Mr. Panote Sirivadhanabhakdi's Director Profile in Enclosure 4, in relation to paragraph (11) of the item "Information on Director seeking re-appointment", which has also been marked in bold. |
| Additional Text | Save as indicated above, the rest of the information in the Invitation to the 2025 AGM remains unchanged. |